Wearable Devices System Diagnoses Mood Disorder in Children and Adolescents

Mood Disorders Clinical Trial

Official title:

A Diagnostic Test of Mood Disorder Recognition in Children and Adolescents Based on Wearable Devices

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT06213220
• Other study ID #: E2KM011639-MDCA
• Status: Recruiting
• Start date: January 3, 2023
• Est. completion date: August 2024

Study information

• Verified date: November 2023
• Source: Institute of Psychology, Chinese Academy of Sciences
• Contact: Fenghua Li, Ph.D
• Phone: +86 13671258804
• Email: lifh[@]psych.ac.cn
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

As a diagnostic test, this study aims to explore the effectiveness of systems based on wearable devices in identifying mood disorders in children and adolescents.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 400
• Est. completion date: August 2024
• Est. primary completion date: June 2024
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 6 Years to 16 Years

Eligibility

Inclusion Criteria:

• Subjects in the MDD group met the DSM-5 diagnostic criteria for MDD and those in the BD group met the DSM-5 criteria for BD

• able to cooperate to complete the study

• had signed the informed consent prior to the study

Exclusion Criteria:

• with severe physical illness

• demonstrated symptoms comorbid with other psychiatric disorders (e.g., schizophrenia, conduct disorder, personality disorder) and developmental disorders (e.g., autism spectrum disorder, intellectual impairment)

• other conditions deemed inappropriate for inclusion in the group

Related Conditions & MeSH terms

• Diagnosis, Psychiatric
• Disease
• Mental Disorders
• Mood Disorders

Locations

Country	Name	City	State
China	Institute of Psychology, Chinese Academy of Sciences	Beijing

Sponsors (1)

Lead Sponsor	Collaborator
Institute of Psychology, Chinese Academy of Sciences

Country where clinical trial is conducted

China, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Other	sensitivity	TP/(TP + FN) = (Number of true positive assessment)/(Number of all positive assessment) It measures the performance of the predictive model based on the primary outcome.	The model fitting will be completed approximately 6 months after the end of the experiment. The report will be available approximately one year after the end of the experiment.
Other	specificity	TN/(TN + FP) = (Number of true negative assessment)/(Number of all negative assessment) It measures the performance of the predictive model based on the primary outcome.	The model fitting will be completed approximately 6 months after the end of the experiment. The report will be available approximately one year after the end of the experiment.
Other	accuracy	(TN + TP)/(TN+TP+FN+FP) = (Number of correct assessments)/Number of all assessments) It measures the performance of the predictive model based on the primary outcome.	The model fitting will be completed approximately 6 months after the end of the experiment. The report will be available approximately one year after the end of the experiment.
Primary	R-R interval	the interval between heart beats derived from Photoplethysmography (PPG)	In the experiment conducted over a period of four weeks, the sampling frequency was 25Hz (based on seconds).The report will be available approximately one year after the end of the experiment.
Primary	Hamilton Depression Rating Scale (HAM-D)	Hamilton Depression Rating Scale (HAM-D) is the most widely used clinician-administered depression assessment scale. The original HAM-D has 21 items, but scoring is based only on the first 17. The patient is rated by a clinician on 17 items scored on a 5-point Likert-type scale. The total score ranges from 0 to 68. A score of 0-7 is considered to be normal while a score of 20 or higher (indicating at least moderate severity) is usually required for entry into a clinical trial.	In the experiment conducted over a period of four weeks, data collection was performed once per week. The report will be available approximately one year after the end of the experiment.
Primary	Young Mania Rating Scale (YMRS)	The Young Mania Rating Scale (YMRS) is one of the most frequently utilized rating scales to assess manic symptoms. The scale has 11 items and is based on the patient's subjective report of his or her clinical condition over the previous 48 hours. Additional information is based upon clinical observations made during the course of the clinical interview. The items are selected based upon published descriptions of the core symptoms of mania. The YMRS follows the style of the Hamilton Rating Scale for Depression (HAM-D) with each item given a severity rating. There are four items that are graded on a 0 to 8 scale (irritability, speech, thought content, and disruptive/aggressive behavior), while the remaining seven items are graded on a 0 to 4 scale. Here's a quick list of what each score range may indicate in a patient: Less than or equal to 12 = remission; 13 -19 = minimal symptoms; 20 - 25 = mild mania; 26 - 37 = moderate mania; 38 - 60 = severe mania	In the experiment conducted over a period of four weeks, data collection was performed once per week. The report will be available approximately one year after the end of the experiment.